SHH and cancer: Deregulated Sonic Hedgehog (SHH) pathway facilitates the initiation, progression and metastasis of NSCLC, confers drug resistance against targeted therapy and renders a lung cancer therapeutic interference option to cancer patients with poor prognosis36–38.